How to Read Sermorelin COA — Verify Purity & Potency

A certificate of analysis (COA) sitting at 97.8% HPLC purity sounds impressive until you realize the peptide sequence was never confirmed by mass spectrometry. Meaning you might have 97.8% pure something, but not necessarily sermorelin. Our team has reviewed hundreds of peptide COAs across suppliers, and the pattern is consistent: most researchers focus exclusively on the HPLC purity percentage while ignoring the three other quality markers that determine whether the compound is actually usable in a research setting. The gap between a legitimate COA and a misleading one comes down to understanding what each test validates. And what it doesn't.

We've guided research institutions through peptide verification protocols for years. The most common procurement error isn't choosing the wrong supplier. It's accepting a COA without cross-referencing the analytical methods listed.

How do you properly read a sermorelin certificate of analysis?

To read a sermorelin COA correctly, verify four markers in sequence: (1) HPLC purity ≥95% confirmed by the chromatogram peak area, (2) peptide sequence verified by mass spectrometry matching the theoretical molecular weight of 3357.88 Da, (3) bacterial endotoxin content below 5 EU/mg, and (4) total peptide content measured by UV spectroscopy at 214 nm. A valid COA must list the analytical method for each claim. Not just the final percentage.

Most COAs fail at the sequence confirmation step. HPLC purity measures how much of the sample is a single compound. It doesn't confirm which compound. You could have 98% purity of a structurally similar but biologically inactive peptide analog. Mass spectrometry closes that gap by matching the molecular weight of your sample to sermorelin's known structure: a 29-amino-acid sequence with the exact formula C149H246N44O42S. This article covers how to interpret HPLC chromatograms, validate mass spec results against theoretical values, assess endotoxin safety thresholds, and identify red flags that indicate a COA was generated without proper testing.

Step 1: Verify HPLC Purity Using the Chromatogram

HPLC (high-performance liquid chromatography) purity is the first marker on every sermorelin COA, typically reported as a percentage between 95% and 99.5%. This number represents the area under the curve for the main peptide peak divided by the total area of all peaks detected. To read a sermorelin COA correctly at this stage, locate the chromatogram image. Usually appended at the end of the document. And confirm the main peak integrates cleanly without shoulder peaks or baseline drift.

A legitimate HPLC purity claim includes the retention time (RT) of the main peak, measured in minutes. Sermorelin typically elutes between 18–22 minutes on a standard C18 reverse-phase column using a water-acetonitrile gradient with 0.1% trifluoroacetic acid. If the COA reports 97% purity but doesn't show the chromatogram or lists an unusually short retention time (under 10 minutes), the purity claim is unsupported. HPLC separates compounds by hydrophobicity. Sermorelin's 29-amino-acid sequence creates a predictable elution profile that skilled suppliers replicate batch to batch.

The chromatogram should show one dominant peak accounting for ≥95% of total UV absorbance at 214 nm, with minor impurity peaks representing truncated sequences, oxidation byproducts, or residual trifluoroacetic acid salts. These impurities are unavoidable in solid-phase peptide synthesis but should collectively represent less than 5% of the sample. Red flag: multiple peaks of similar height, which suggests incomplete synthesis or degradation during storage.

Step 2: Confirm Peptide Identity with Mass Spectrometry

HPLC purity alone cannot confirm you received sermorelin. It only confirms you received something pure. Mass spectrometry (MS) closes that verification gap by measuring the molecular weight of your peptide and comparing it to sermorelin's theoretical mass: 3357.88 Da (daltons). To properly read a sermorelin COA, locate the mass spec section and verify the observed mass falls within ±1 Da of the expected value. Most COAs report this as "MS (ESI): calculated 3357.88, found 3357.2" or similar notation.

Electrospray ionization mass spectrometry (ESI-MS) ionizes the peptide without fragmenting it, producing a spectrum that shows the intact molecular ion. Sermorelin's MS spectrum typically displays multiple charged states. Doubly charged (M+2H)²⁺ at approximately 1679 m/z and triply charged (M+3H)³⁺ at approximately 1120 m/z. The presence of these charge states, combined with a deconvoluted mass matching the theoretical value, confirms the peptide sequence is correct.

Without mass spec data, you're trusting the supplier synthesized the correct 29-amino-acid sequence without deletions, substitutions, or truncations. HPLC cannot differentiate between sermorelin and a 28-amino-acid analog missing the C-terminal alanine. Both might show 97% purity but only one is biologically active. At Real Peptides, every batch undergoes ESI-MS verification before shipment because sequence confirmation is non-negotiable for research-grade peptides.

Step 3: Assess Endotoxin Levels and Total Peptide Content

Bacterial endotoxin contamination is the hidden quality failure most researchers miss when they read a sermorelin COA. Endotoxins are lipopolysaccharides shed by gram-negative bacteria during fermentation or purification. They survive lyophilization and trigger immune responses in cell culture and animal models even at sub-nanogram concentrations. The FDA recommends endotoxin limits below 5 EU/mg (endotoxin units per milligram) for research peptides. To verify this, locate the LAL (Limulus amebocyte lysate) assay result on the COA. It should state "<5 EU/mg" or provide a specific value like "2.3 EU/mg."

Total peptide content, measured by UV spectroscopy at 214 nm, tells you how much of the vial's stated weight is actually peptide versus residual salts, moisture, or lyophilization buffer. A vial labeled "5 mg sermorelin" might contain 4.2 mg peptide and 0.8 mg trifluoroacetic acid salts. The COA should report this as 84% peptide content by weight. This matters for dosing accuracy: if you reconstitute assuming 5 mg but only 4 mg is peptide, your working concentration is 20% lower than calculated.

Combining HPLC purity, mass spec confirmation, endotoxin testing, and peptide content gives you a complete quality profile. HPLC answers "how pure?", mass spec answers "is it sermorelin?", endotoxin testing answers "is it safe?", and peptide content answers "how much usable compound?". Skipping any of these four markers when you read a sermorelin COA means accepting incomplete verification. Research-grade suppliers provide all four data points on every batch. If a COA omits mass spec or endotoxin results, request them before proceeding.

Sermorelin COA Quality Markers: Comparison

Key Takeaways

• HPLC purity ≥95% confirms a single dominant compound but does not verify the peptide sequence. Mass spectrometry is required to confirm you received sermorelin and not a structurally similar analog.
• Mass spectrometry matching 3357.88 Da ±1 Da is the only analytical method that confirms the 29-amino-acid sermorelin sequence was synthesized correctly without deletions or substitutions.
• Bacterial endotoxin levels above 5 EU/mg can trigger immune responses in cell culture and animal models even when the peptide itself is chemically pure.
• Total peptide content below 80% by weight means a significant portion of the vial is residual trifluoroacetic acid salts or moisture. Adjust reconstitution calculations accordingly.
• A valid COA must list the analytical method for every claim (e.g., "HPLC using C18 column, 214 nm detection"). Percentage values without methodology are unverifiable.

What If: Sermorelin COA Scenarios

What If the COA Shows 98% HPLC Purity but No Mass Spec Data?

Request mass spectrometry confirmation before using the peptide. HPLC purity alone cannot verify you received sermorelin. It only confirms the sample is mostly one compound, which could be a truncated sequence, oxidized analog, or entirely different peptide with similar retention time. Suppliers who omit mass spec data either lack the equipment to perform the test or are concealing sequence errors. Research-grade peptide suppliers provide ESI-MS results on every batch as standard practice.

What If the Observed Molecular Weight Is 3340 Da Instead of 3357.88 Da?

A 17-dalton mass discrepancy suggests a structural modification or synthesis error. Possibly a missing hydroxyl group or substituted amino acid. Do not use the peptide without contacting the supplier for clarification. Mass differences this large indicate the peptide sequence does not match sermorelin's published structure. Legitimate COA variances are ±1 Da due to instrument calibration. Not ±17 Da.

What If Endotoxin Levels Are Listed as "Not Tested" or Omitted Entirely?

Assume endotoxin contamination risk is uncontrolled and request LAL assay results. Peptides synthesized in non-sterile environments or purified using bacterial expression systems can carry endotoxin levels exceeding 50 EU/mg. Well above the 5 EU/mg safety threshold. For in vitro studies, this triggers inflammatory cytokine release that confounds experimental results. For in vivo work, it causes fever and immune activation independent of the peptide's biological effect.

The Unvarnished Truth About Sermorelin COAs

Here's the honest answer: most researchers read sermorelin COAs wrong because they treat the purity percentage as a final quality score instead of the first checkpoint in a four-part verification protocol. We've reviewed COAs from suppliers across three continents, and the pattern is relentless. HPLC purity gets reported prominently while mass spec data is buried in fine print or omitted entirely. That omission isn't accidental. Confirming peptide identity costs more than running a purity assay, and suppliers targeting price-sensitive buyers know most customers won't request the missing data.

A COA without mass spectrometry confirmation is an incomplete document. HPLC tells you the sample is pure; mass spec tells you it's the right peptide. Without both, you're trusting synthesis accuracy on faith. And synthesis errors (wrong amino acid incorporated, premature chain termination, oxidation during cleavage) happen frequently enough that sequence confirmation is standard practice at every research-grade facility. If your supplier cannot provide ESI-MS data matching 3357.88 Da within ±1 Da, you do not have verified sermorelin. Period.

You're not reading a sermorelin COA correctly unless you've checked four markers: HPLC purity ≥95%, mass spec matching the theoretical molecular weight, endotoxin levels below 5 EU/mg, and total peptide content ≥80% by weight. Anything less is incomplete verification. And incomplete verification means experimental results built on uncertain compound identity. The COA exists to prove what's in the vial matches what the label claims. If the document cannot do that, request better documentation or find a supplier who provides it as standard.

When COA Red Flags Demand Supplier Clarification

Before trusting any sermorelin COA, scan for these integrity markers that separate verified peptides from under-tested compounds. Missing chromatograms, vague analytical method descriptions (e.g., "tested by HPLC" without column type or detection wavelength), or endotoxin results listed as "pending" indicate the COA was issued before testing finished. Or testing was never performed. Legitimate suppliers append raw chromatograms and mass spectra directly to the COA rather than summarizing results in a text table.

Batch numbers matter more than most researchers realize. Every COA should reference a unique batch identifier that traces back to synthesis records, purification logs, and lyophilization parameters. If the COA lists "Batch: Sermorelin" without a date code or alphanumeric identifier, you cannot verify whether the document corresponds to your specific vial. Cross-reference the batch number on the COA with the label on your vial. Mismatches indicate either clerical error or reused documentation.

Retention time consistency across batches is a secondary verification point. If your supplier provided sermorelin COAs for three previous orders, compare the HPLC retention times. Sermorelin should elute at approximately the same point (±0.5 minutes) on identical column and gradient conditions. A retention time shift from 19.2 minutes to 14.8 minutes between batches suggests either a different peptide, column degradation, or method inconsistency. All of which undermine confidence in the purity claim.

COA authenticity is verifiable through third-party testing. If the reported purity, molecular weight, or endotoxin level seems inconsistent with previous batches, send a sample to an independent analytical lab for HPLC and mass spec confirmation. This costs $150–$300 per analysis but definitively answers whether your supplier's COA reflects reality. We've seen researchers operate for months on peptides that tested 12 percentage points lower in purity than the COA claimed. The cost of independent verification is negligible compared to experimental time lost on unreliable compounds.

Proper interpretation of a sermorelin COA requires cross-referencing four analytical methods, verifying batch traceability, and maintaining supplier accountability through periodic third-party testing. HPLC purity is the attention-grabbing headline; mass spec confirmation is the substance. Endotoxin testing is the safety gate; peptide content is the dosing foundation. Miss any one of these checkpoints when you read a sermorelin COA, and you're operating on incomplete quality assurance. Which means your research conclusions rest on unverified compound identity. That's not a risk serious labs accept.

For researchers committed to reproducible results, COA literacy isn't optional. It's the gatekeeper between verified peptides and expensive guesswork. You can explore other high-purity research compounds through our full peptide collection, where every batch ships with complete HPLC, mass spec, endotoxin, and peptide content documentation as standard.